Daphne Karydas Insider Trades & Stock Holdings
Daphne Karydas at Mineralys Therapeutics, Inc. has 2 Form 4 trades on file since Jun 17, 2026. Open-market activity: 0 purchases ($0) and 1 sale ($75K), net -$75K. Latest filing: disposed of 3K shares of $MLYS on Jun 17, 2026 at $25.
- Trades on file
- 2
- Open-market bought
- $0
- Open-market sold
- $75K
- Net open-market
- -$75K
- Latest filing
- Jun 17, 2026
All insider trades by Daphne Karydas
| Date | Ticker | Type | Shares | Price | Value | Owned after | ΔOwn | 1W | 1M | 6M | Role | Filing | Story |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $MLYS | Sell (Open-market sale) 10b5-1 | 3K | $25 | $75K | +2.5% | +7.8% | Read | ||||||
| $MLYS | Buy (Option exercise) | 3K | $12.02 | $36.06K | +2.5% | +7.8% | Read |
"Buy" means shares acquired on the Form 4 (including grants and option exercises); "Sell" means shares disposed. 1W / 1M / 6M = how the stock moved after the trade.
Stocks Daphne Karydas traded
Frequently asked questions
Has Daphne Karydas been buying or selling stock?
Daphne Karydas has 0 open-market purchases and 1 open-market sale on file, net -$75K. Grants, option exercises and tax withholding are listed separately because they are not open-market trades.
What was Daphne Karydas's latest insider trade?
disposed of 3K shares of $MLYS on Jun 17, 2026 at $25.
Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.
Get a text when insiders, Congress or big funds trade a stock.
Free. Reply STOP anytime.